Santa Fe Precision Oncology Symposium

Santa Fe, NM US
October 19, 2024

This accredited continuing education activity, Santa Fe Precision Oncology Symposium, is designed to improve the care of cancer patients by educating cancer care providers about precision oncology. This oncology conference features leading experts in the field of precision oncology who will provide a comprehensive overview of the implications of actionable molecular alterations across common malignancies.
This activity is designed to facilitate learning, improve knowledge retention, and inspire participants to implement the newly acquired knowledge into their clinical practice. Through didactic lectures, case-based discussions, and interactive questions and answer sessions, participants will be able to ask relevant questions, clarify concerns, and network with expert faculties. 

Target Audience

  • Hematologists/ Oncologists
  • Oncology Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses
  • Researchers and others

 

ORGANIZING COMMITTEE: 

Course Director:

Binay Shah, MD, MHA - Binaytara Foundation

Conference Chair:

Fei Gu, MD, PhD - Nexus Health

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Review the current and emerging paradigms in precision oncology and plan precision-guided management of various malignancies.
  • Explain the roles, advantages, and disadvantages of different testing methodologies for guiding targeted therapies, including the appropriate timing for these tests.
  • Interpret the concept of “tumor agnostic” therapeutics and identify opportunities to optimize treatment logistics and manage side effects across different malignancies.
  • Identify collaboration opportunities among regional providers to optimize patient care through enhanced access to clinical trials available at cancer centers in the region.

HOTEL INFORMATION

Coming Soon

GLOBAL ONCOLOGY PROJECT

Click this link to learn more about our ongoing project building a 200-bed cancer hospital in Nepal: https://binayfoundation.org/cancer-hospital/

Course summary
Available credit: 
  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.
Course opens: 
05/06/2024
Course expires: 
01/19/2025
Event starts: 
10/19/2024 - 8:00am PDT
Event ends: 
10/19/2024 - 5:00pm PDT
Cost:
$350.00

OCTOBER 19, 2024

All times are listed in Mountain Daylight Time (MDT)

07:00 AM – 08:00 AM  Registration, Breakfast, & Exhibits


07:30 AM – 07:35 AM  Welcome

07:35 AM – 08:00 AM  Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD, MHA


08:00 AM – 09:00 AM  Session 1 - NGS & Beyond: Tools in Precision Oncology

Session Chair: Mohammad Vasef, MD

08:00 AM – 08:20 AM  Tissue-Based NGS Testing - Y. Lynn Wang, MD, PhD, FCAP

08:20 AM – 08:40 AM  Liquid Biopsy and ctDNA - Jordan Paul Redemann, MD

08:40 AM – 09:00 AM  Case-Based Discussion - Mohammad Vasef, MD


09:00 AM – 10:30 AM  Session 2 - Targeted Therapies

Session Chair: Ethan Binder, MD

09:00 AM – 09:20 AM  Acute Leukemia: Where Do We Stand Now? - Musa Yilmaz, MD

09:20 AM – 09:40 AM  Receptor Tyrosine Kinases: The NSCLC Story

09:40 AM – 10:00 AM  The Hormonal Pathway and Overcoming Humoral Resistance: The  HR+HER2- Story

10:00 AM – 10:30 AM  Panel Discussion


10:30 AM – 11:00 AM  Break & Exhibits


11:00 AM – 12:00 PM  Session 3 - Tumor Agnostic Treatment

Session Chair: 

11:00 AM – 11:30 AM  Keynote Speech 

11:30 AM – 12:00 PM  Panel Discussion 


12:00 PM – 01:00 PM  Lunch & Exhibits


01:00 PM – 02:00 PM  Session 4 - Therapeutic Antibodies

Session Chair: Shashank Cingam, MD

01:00 PM – 01:20 PM  Enfortumab in Bladder Cancer 

01:20 PM – 01:40 PM  Bispecific Antibodies: Opportunities and Challenges 

01:40 PM – 02:00 PM  Panel Discussion 


02:00 PM – 03:00 PM  Session 5 - Precision Oncology: Focus on Delivery

Session Chair: Malcolm Purdy, MD

02:00 PM – 02:20 PM  IO in Early Stage Cancers

02:20 PM – 02:40 PM  Radionuclide in Diagnosis and Therapy

02:40 PM – 03:00 PM  Case-Based Discussion 


03:00 PM – 03:30 PM   Break & Exhibits


03:30 PM – 04:30 PM  Session 6 - Managing Toxicities

Session Chair: Neda Hashemi, MD

03:30 PM – 03:50 PM Managing Side Effects in Oral Oncolytics - Jessica M Lewis-Gonzalez, PharmD, BCOP &  Mary T Young, PharmD

03:50 PM – 04:10 PM  Managing Toxicities of ADCs

04:10 PM – 04:30 PM  Panel Discussion


04:30 PM – 05:15 PM  Session 7 - Access to Clinical Trials

Session Chair: Bryan Goss, MD

04:30 PM – 04:45 PM  Clinical Trial Design and Endpoints in the Era of Precision Oncology - Weijing Sun, MD, FACP

04:45 PM – 05:15 PM  Panel Discussion


05:15 PM  Adjourn

Hilton Santa Fe Historic Plaza
100 Sandoval St
Santa Fe, NM 87501
United States
Faculty Information Coming Soon

 

Session Chair(s)

Ethan Binder, MD

has no relevant financial relationships to disclose at this time.

Malcolm Purdy

has no relevant financial relationships to disclose at this time.

Mohammad Vasef, Academic pathologist, board certified by American Board of Pathology in AP/CP, Hematopathology, and Molecular Genetic Pathology

has a financial relationship (Professional Services) with Roche Diagnostics;.
Speaker/Topic Presenter(s)

Y. Wang

has no relevant financial relationships to disclose at this time.
Case Presenter(s)

Available Credit

  • 7.25 ABIM MOC II
    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
  • 7.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 7.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 7.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 7.25 Contact Hours.

If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information

 

Price

Cost:
$350.00
Please login or register to take this course.

POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE: 

All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place. 

The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference.  The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees. 

If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.

Violating this policy will result in a fine equivalent to a general display fee for that conference. 

 

NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:

If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:

  • If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
  • If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event. 
  • If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event. 

Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.

CANCELLATION POLICY

You may cancel your enrollment at any time. Cancellation fees apply as below:

  • 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
  • No refunds will be issued if registration is canceled after that date.  

No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.